BioSig Technologies Soars 33.85% on $1.1B Financing Deal

BioSig Technologies' stock surged by 33.85% in pre-market trading on July 8, 2025, marking a significant rise in investor interest and confidence in the company's future prospects.

BioSig Technologies has secured up to $1.1 billion in growth financing through definitive agreements with institutional investors. This financing is aimed at launching a gold-backed treasury management strategy and rapidly expanding real-world asset tokenization for the commodities markets.

The funding includes $100 million in senior secured convertible debentures and a $1 billion equity line of credit. The debentures carry a 4% annual interest rate, providing a stable financial foundation for the company's expansion plans.

BioSig Technologies' wholly owned subsidiary, Streamex Exchange, has entered into a $1.1 billion financing agreement to advance their gold-backed treasury management strategy. This strategic move is expected to significantly enhance the company's capabilities in the commodities markets.